Get started
Author

David Dilley

Observed name: D. Dilley
Institution: GenesisCare
OpenAlex ID: A5111599732
Structural characterization of a cross-reactive idiotype shared by monoclonal antibodies specific for the human CD4 molecule
1991 · R. Attanasio, D. Dilley, et al. · Journal of Biological Chemistry · 14
Toxicities and Quality of Life following Observation or Radiation Therapy for Dupuytren’s Disease: Three-Year Secondary Analysis Data From the Prevention Group of the International Dupuytren's Evaluation of Preventative or Adjuvant Radiation Therapy (DEPART) Randomized Trial
2025 · Jarad M. Martin, Tanya Burgess, et al. · International Journal of Radiation Oncology*Biology*Physics · 7
Resistant herpes infection of the palm in a patient with acquired immunodeficiency syndrome: A case report
1997 · David Dilley, Robert G. Chandler, et al. · The Journal Of Hand Surgery · 5
Invasive Strategy With Intended Percutaneous Coronary Intervention Versus Conservative Treatment in Older People With ST‐Segment–Elevation Myocardial Infarction: A Meta‐Analysis
2025 · Sascha Macherey‐Meyer, David Dilley, et al. · Journal of the American Heart Association · 2
Quality of Life and Toxicities Following Whole-Palm Versus Involved-Field Radiation Therapy for Dupuytren’s Disease: A Substudy From a Randomized Trial
2026 · Renee Duvenage, Jarad M. Martin, et al. · Advances in Radiation Oncology
Quality of Life and Toxicities Following Whole-Palm vs. Involved-Field Radiotherapy for Dupuytren’s Disease: A Sub-Study from a Randomized Trial
2026 · R. Duvenage, J.M. Martin, et al. · International Journal of Radiation Oncology*Biology*Physics
Works count: 6
Citation count: 28
H-index: 3
I10-index: 1
Year
Topic
Type